126 related articles for article (PubMed ID: 1685293)
1. Mechanisms of serotonergic affect control.
Kennett GA
Adv Exp Med Biol; 1991; 294():231-43. PubMed ID: 1685293
[No Abstract] [Full Text] [Related]
2. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
Meller E; Goldstein M; Bohmaker K
Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
[TBL] [Abstract][Full Text] [Related]
3. Effect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injection.
Higgins GA; Jones BJ; Oakley NR
Psychopharmacology (Berl); 1992; 106(2):261-7. PubMed ID: 1347954
[TBL] [Abstract][Full Text] [Related]
4. (-)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists.
Sprouse JS; Aghajanian GK
Eur J Pharmacol; 1986 Sep; 128(3):295-8. PubMed ID: 2878817
[TBL] [Abstract][Full Text] [Related]
5. Behavioural and biochemical consequences following activation of 5HT1-like and GABA receptors in the dorsal raphé nucleus of the rat.
Higgins GA; Bradbury AJ; Jones BJ; Oakley NR
Neuropharmacology; 1988 Oct; 27(10):993-1001. PubMed ID: 2467224
[TBL] [Abstract][Full Text] [Related]
6. Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone.
Davis M; Cassella JV; Kehne JH
Psychopharmacology (Berl); 1988; 94(1):14-20. PubMed ID: 2894698
[TBL] [Abstract][Full Text] [Related]
7. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test.
Söderpalm B; Hjorth S; Engel JA
Pharmacol Biochem Behav; 1989 Jan; 32(1):259-65. PubMed ID: 2567524
[TBL] [Abstract][Full Text] [Related]
8. Limbic mechanisms of anxiolytics acting on 5-HT receptors.
Płaźnik A; Kostowski W; Stefański R
Pol J Pharmacol; 1994; 46(5):473-7. PubMed ID: 7894537
[TBL] [Abstract][Full Text] [Related]
9. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
[TBL] [Abstract][Full Text] [Related]
10. Differential behavioural activation following intra-raphe infusion of 5-HT1A receptor agonists.
Higgins GA; Elliott PJ
Eur J Pharmacol; 1991 Feb; 193(3):351-6. PubMed ID: 1675996
[TBL] [Abstract][Full Text] [Related]
11. 5-HT1A agonist activity of pindolol: reversal of the inhibitory effects on cell firing in the dorsal raphe nucleus but not in the hippocampus by WAY-100,635.
Sprouse J; Braselton J; Reynolds L
Ann N Y Acad Sci; 1998 Dec; 861():274-5. PubMed ID: 9928287
[No Abstract] [Full Text] [Related]
12. Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone.
Carli M; Prontera C; Samanin R
Br J Pharmacol; 1989 Apr; 96(4):829-36. PubMed ID: 2568143
[TBL] [Abstract][Full Text] [Related]
13. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
Wieland S; Kreider MS; McGonigle P; Lucki I
Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505
[TBL] [Abstract][Full Text] [Related]
14. Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligands.
Mansbach RS; Geyer MA
Eur J Pharmacol; 1988 Nov; 156(3):375-83. PubMed ID: 2975225
[TBL] [Abstract][Full Text] [Related]
15. Reversal of helpless behavior in rats by putative 5-HT1A agonists.
Giral P; Martin P; Soubrié P; Simon P
Biol Psychiatry; 1988 Feb; 23(3):237-42. PubMed ID: 2892540
[TBL] [Abstract][Full Text] [Related]
16. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.
Moser PC; Tricklebank MD; Middlemiss DN; Mir AK; Hibert MF; Fozard JR
Br J Pharmacol; 1990 Feb; 99(2):343-9. PubMed ID: 1970269
[TBL] [Abstract][Full Text] [Related]
17. 5-HT3 receptor-active drugs alter development of spinal serotonergic innervation: lack of effect of other serotonergic agents.
Bell J; Zhang XN; Whitaker-Azmitia PM
Brain Res; 1992 Feb; 571(2):293-7. PubMed ID: 1535269
[TBL] [Abstract][Full Text] [Related]
18. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
[TBL] [Abstract][Full Text] [Related]
19. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
[TBL] [Abstract][Full Text] [Related]
20. Serotonergic neurons in the median raphe nucleus regulate inhibitory avoidance but not escape behavior in the rat elevated T-maze test of anxiety.
Dos Santos L; de Andrade TG; Zangrossi H
Psychopharmacology (Berl); 2005 Jun; 179(4):733-41. PubMed ID: 15619105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
